
Sign up to save your podcasts
Or


Apple is reportedly planning to significantly improve its healthcare app and introduce an AI Doctor feature in the spring of 2026. This will allow AI to analyze biometric data collected from wearable devices such as the Apple Watch and provide personalized health advice to users. Following this trend, other wearable companies such as Whoop and Oura have also implemented AI agent functions, and it is expected that AI doctor functions will become standard in wearable devices in the future. Behind this is FHIR, a technology that facilitates linkage with electronic medical records, which has already become widespread in the U.S., but Japan is lagging behind. Google is making similar moves, but Apple is ahead of the pack and has established a leading position in the integration of wearable healthcare and AI.
M3 plans to acquire 51.0% of Ewell's shares from Tokyu Land Corporation for ¥10.2 billion, making it a subsidiary of M3 as of April 1, 2025.
On November 14, 2023, M3 announced plans to conduct a TOB (takeover bid) for Benefit One, which is owned by Pasona Group, to make it a subsidiary.
However, Dai-ichi Life Insurance conducted a TOB, a takeover bid without consent, at ¥2,173 per share, which was much higher than M3's offer price (¥1,600), and Benefit One agreed to this offer, resulting in Dai-ichi Life becoming a wholly owned subsidiary. In other words, M3 lost the TOB battle.
This podcast examines the current status and challenges of the genetic testing market, especially the limitations of its business model and new strategies for the future against the backdrop of 23andMe's plummeting stock price. While introducing the trends of major domestic and overseas players, the article proposes solutions to the challenges of monetization, such as the introduction of a subscription model and a shift to a BtoB business. It also points out the importance of structural mutation analysis and multi-omics analysis as added value other than SNP analysis, and discusses issues in collaboration with pharmaceutical companies and the necessary sample size.
In this podcast, the University of Tokyo startup issin explains how it launched its sleep-focused Smart Recovery Ring and provides an overview of the product. While comparing the ring to its predecessor, the Oura ring, the PodCast also touches on the sensors and component configurations required for the smart ring, as well as an estimate of development costs, suggesting that the technological hurdles may be lower than before. It is suggested that the technical hurdles may be lower than before. Therefore, it concludes that marketing and branding, as well as technological capabilities, will be key to competition in the future.
This podcast discusses how Oura Ring, a pioneer in the smart ring market, can maintain its competitive advantage even after competitors enter the market. factors that helped Oura overcome its initial challenges and gain user acceptance include its focus on improving sleep quality, product improvements, sleek design, and celebrity marketing strategies. On the other hand, latecomers are entering the market with buy-one-get-one models and low prices, and competition is expected to intensify in the future. However, Oura has established a stable revenue stream through high customer engagement and a subscription model, which differentiates it from its competitors.
Learn about four innovative healthcare products presented at CES 2025. Cure Silk, a chronic wound care solution, combines an AI app with a silk elastin patch. The battery-free Smart Diaper generates electricity from urine as an electrolyte and notifies the user when he or she urinates; Eli Health's Hormometer, a home hormone testing device, offers a simple saliva-based test; and the Hormometer, a new product from the company's Hormone Testing Lab, offers a simple, easy-to-use saliva-based test for hormone levels in the body. Finally, Withings' AI-powered smart mirror measures body composition and provides health advice. The features of each product and their potential in the market are discussed.
This document is a discussion of the third quarter 2024 financial report of online healthcare services provider Hims & Hers, Inc. The company's success factors include personalized medicine using electronic medical records and AI/machine learning and a competitive pricing strategy. In personalized medicine, the report highlights the company's ability to achieve high treatment retention rates by adjusting drug formulations and dosages according to the patient's condition. The report also analyzes the company's efforts to improve access to low-income and elderly populations, as well as its competitive differentiation strategy.
This podcast discusses the current status and future projections regarding the use of large-scale language models (LLMs) to support the creation of referral letters and discharge summaries in the medical field. Examples from Japan and overseas, including OpTim, Infocom, and a demonstration experiment between Mie University and NTT, are introduced, and the importance of linking with electronic medical records and the approaches taken by new entrants (OCR technology, stand-alone applications, building local LLMs, etc.) are discussed. In particular, it is expected that electronic medical record manufacturers will lead the development of this field, and the possibility of commoditization in the near future is suggested.
Translated with DeepL.com (free version)
A report on Intuitive Surgical's Da Vinci surgical robot Q3 2024 financial results and a competitive analysis of the market, showing Da Vinci's high market share (approximately 80%) and high profitability (Recurring Revenue 83%), as well as an analysis of Intuitive Surgical's competitors, including Stryker, Johnson & Johnson, and Medtronic. The report also analyzes the trends of competitors such as Stryker, Johnson & Johnson, and Medtronic, especially their low-cost strategies and expansion into emerging markets, which could threaten Intuitive Surgical's future dominance of the market. While Da Vinci's dominance is expected to be maintained in the short term, concerns about increased competition in the long term are also expressed.
Hippocratic AI, a company advancing the development of healthcare-focused large language models (LLMs) under the name "Polaris," has announced that it has been granted a patent by the United States Patent and Trademark Office. Polaris' "Constellation Architecture" leverages a system where multiple specialized models work collaboratively, rather than relying on a single model. This innovative design enhances both accuracy and safety simultaneously.
Let’s examine the mechanism in detail based on the publicly available patent information.
From the publisher's feed